Authors
Latest:
ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery mattersA significant proportion of cataract surgery patients exhibit hyperosmolar tear film both before and 1 month after surgery, underscoring preoperative screening and postoperative management to optimize visual outcomes.
Latest:
Cyclosporine drop for treating dry eye offers new advantagesDelivered in a water-free solution, Vevye’s new formulation offers a high concentration of cyclosporine that works rapidly, has no preservatives, and rarely causes irritation
Latest:
One shingle at a time: Starting a solo practiceSometimes, the best job for you is the one you create.
Latest:
Shaffer-Hetherington-Hoskins Lecture at the 2025 Glaucoma 360 meetingM. Roy Wilson, presented the Shaffer-Hetherington-Hoskins Lecture at the Glaucoma 360 meeting held in San Francisco, California. This lecture was entitled, "Rethinking Race as a Risk Factor for Glaucoma: What Really Matters?"
Latest:
IVIg, ICVM may help patients with small fiber neuropathy, neuropathic corneal painNCP should be considered for patients with discomfort, irritation, dryness, grittiness.
Latest:
Robert Maloney, MD, announces retirement from clinical practiceFollowing his keynote address at Controversies in Modern Eye Care, Dr. Maloney said he will be leaving his surgical practice and returning to research.
Latest:
Tuning out anxiety: the role of music in cataract surgeryFrom easing fears to improving mood, a recent study explores how music transforms the surgical experience for both patients and health care teams.
Latest:
Study examines efficiency of physiotherapy in treating, preventing uncomplicated acquired myopiaResearch explores innovative physiotherapeutic approaches to managing myopia progression, showing promising results in slowing its advancement over two years.
Latest:
ARVO 2025: PAVIA 12-month results in nonproliferative diabetic retinopathyAt ARVO 2025, in Salt Lake City, Utah, David Almeida, MD, MBA, PhD, talked about 12-month results from the PAVIA phase 2 trial of EYP-1901 in nonproliferative diabetic retinopathy.
Latest:
Q&A: Rachel Downes, MD, provides highlights from the GATHER1 and GATHER2 clinical trials for GADiscover how ellipsoid zone integrity predicts geographic atrophy growth rates in recent clinical trials, enhancing future treatment strategies.
Latest:
The Residency Report: Clinical insights from the iStent infinite trialA conversation with David S. Friedman, MD, PhD, on treating uncontrolled open-angle glaucoma in patients with limited options
Latest:
Welcome to the metaverse: Technology allows ophthalmologists to mingle with colleagues worldwideAnswers to common questions that can help kick-start the journey into the metaverse to learn from the many virtual educational meetings and conference opportunities while mingling with colleagues worldwide.
Latest:
50 years of ophthalmology: What changed the game (Part 1)In honor of Ophthalmology Times’ 50th anniversary, anterior segment surgeons attending ASCRS 2025 weigh in on the innovations that defined modern ophthalmology.
Latest:
Mercy Ships delivers a lifeline for eye health in Africa’s remote communitiesThrough its ophthalmic program, Mercy Ships provides critical eye surgeries and trains local professionals, ensuring sustainable eye care for the future.
Latest:
ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma managementGlaucoma management is shifting toward earlier, drop-sparing interventions using sustained drug delivery and advanced laser technologies that improve outcomes and quality of life for both patients and physicians.
Latest:
Q&A: Brandon D. Ayres, MD, on streamlining anterior vitrectomy with a high-speed, small-gauge probe at ASCRS 2025Ayres shares insights on using a trocar-free, 27-gauge vitrector to improve surgeon comfort and patient safety in anterior vitrectomy
Latest:
Demodex Blepharitis in a Contact Lens Wearer: Treatment Plan and OutcomesA panelist discusses how treating demodex blepharitis with Lotilaner not only eliminates the anterior blepharitis symptoms but also improves meibomian gland function, with low recurrence rates after treatment and significant benefits for patient comfort and quality of life.
Latest:
Artificial intelligence enhances detection of neuro-ophthalmic disordersDeep learning discerns IIH, NAION, and normal eyes using single fundus image.
Latest:
Tools can detect corneal nerve damage earlyNoncontact esthesiometry screens for all levels of neurotrophic keratitis.
Latest:
Investigators research ocular health after space flightSpaceflight-associated neuro-ocular syndrome a potential challenge during long missions.
Latest:
Next-generation MGD: Patients in their 20s, 30s offer new perspectivesLong-term screen users and contact lens wearers in group face challenges.
Latest:
Under-eye filler: Cannula vs needle in tear trough treatmentUnderstand the anatomical risks, technique-specific benefits, and patient selection criteria
Latest:
ARVO 2025: Lipid metabolism altered by CFH (Y402H) polymorphism and chronic oxidative stress in iPSC-derived RPE cellsAt ARVO 2025, in Salt Lake City, Utah, Peng Shang, PhD, talked about her presentation on how the Y402H polymorphism of Complement Factor H (CFH), a major genetic risk factor for AMD, and chronic oxidative stress affect the lipid profile of retinal pigment epithelial (RPE) cells.
Latest:
The impact of preservatives on the ocular surface in patients with ocular hypertension or glaucomaWeighing the benefits and trade-offs of preserved versus preservative-free glaucoma treatments is key to optimizing long-term patient care.
